Insider Trading February 5, 2026

Cadence Senior Executive Disposes of $295K Stake Amid Stock Weakness

Paul Cunningham sells 1,000 shares; company readies earnings report while unveiling a new DSP and adding a research leader to the board

By Maya Rios CDNS
Cadence Senior Executive Disposes of $295K Stake Amid Stock Weakness
CDNS

Cadence Design Systems Sr. Vice President Paul Cunningham sold 1,000 shares on February 2, 2026, for $295,090 under a pre-existing Rule 10b5-1 plan. The sale coincides with a recent pullback in the stock and precedes an upcoming earnings report; the company has also announced a new DSP product and a board appointment.

Key Points

  • Insider sale: 1,000 shares sold on February 2, 2026 under a Rule 10b5-1 plan; Cunningham owns 95,137 shares after the sale.
  • Cadence trading context: stock down 10.32% over the past week and trading at $271.42; earnings due February 17 with analyst targets from $275 to $410.
  • Company updates: launch of Tensilica HiFi iQ DSP with reported compute, AI and energy gains; Dr. Luc Van den hove appointed to the board effective January 1, 2026.

Paul Cunningham, senior vice president at Cadence Design Systems Inc, completed the sale of 1,000 shares of the company’s common stock on February 2, 2026, at $295.09 per share, yielding proceeds of $295,090.

The trade occurred as Cadence shares have fallen 10.32% over the previous week and were trading at $271.42 at the time the report was prepared. InvestingPro data cited in the filing indicates the stock is in oversold territory.

Following the disposition, Cunningham retains direct ownership of 95,137 Cadence shares. The transaction was carried out pursuant to a Rule 10b5-1 trading plan that Cunningham adopted on March 14, 2025. The regulatory filing also states that the total securities beneficially owned includes 70 shares acquired under the company Employee Stock Purchase Plan on January 30, 2026.

Investors should note that Cadence is set to report quarterly results on February 17, 2026. Analysts’ price targets cited in the filing range from $275 to $410. The filing also references additional resources available through InvestingPro, including 16 supplemental tips and a comprehensive Pro Research Report on CDNS, which is listed among more than 1,400 U.S. equities covered with in-depth analysis.

Alongside insider activity and the forthcoming earnings release, Cadence recently disclosed a new product and a board-level appointment. The company introduced the Tensilica HiFi iQ digital signal processor, part of the sixth generation of the HiFi DSP family. Cadence describes the HiFi iQ as engineered for next-generation voice AI and immersive audio applications.

According to the company’s announcement, the Tensilica HiFi iQ delivers a twofold increase in compute performance and an eightfold improvement in AI performance compared with the prior HiFi 5s DSP. The company also reports that the new processor achieves over 25% energy savings for most workloads and provides a 40% performance uplift on various audio codecs.

Cadence has also named Dr. Luc Van den hove to its board of directors effective January 1, 2026. Dr. Van den hove currently serves as CEO of imec, a research and innovation hub in nanoelectronics and digital technologies. The filing notes that he has been with imec since its inception in 1984 and has been president and CEO since 2009.

These corporate moves - the insider sale, an imminent earnings report, the product launch and the board appointment - are presented in the filings and announcements reviewed. The documents do not tie the insider sale to any specific company development, and they do not provide further commentary beyond the factual disclosures noted above.


Summary

Cadence senior vice president Paul Cunningham sold 1,000 shares on February 2, 2026, for $295,090 under a Rule 10b5-1 plan. The stock has fallen about 10.32% over the prior week and traded at $271.42. Cadence will report earnings on February 17. Separately, the company introduced the Tensilica HiFi iQ DSP and appointed Dr. Luc Van den hove to its board, effective January 1, 2026.

Key points

  • Insider transaction: Paul Cunningham sold 1,000 shares on February 2, 2026, at $295.09 per share for $295,090, executed under a March 14, 2025 Rule 10b5-1 plan; Cunningham now directly owns 95,137 shares.
  • Market context and catalysts: The stock declined 10.32% in the past week and was trading at $271.42; Cadence is due to report earnings on February 17 with analyst price targets from $275 to $410.
  • Corporate developments: Cadence launched the sixth-generation Tensilica HiFi iQ DSP with reported compute, AI, energy and codec performance gains, and added Dr. Luc Van den hove to its board effective January 1, 2026.

Risks and uncertainties

  • Share-price volatility: The stock’s recent 10.32% decline and current trading level at $271.42 reflect short-term market movement that could affect investor sentiment in the technology and semiconductor sectors.
  • Earnings outcome: Cadence’s results announced on February 17 could materially influence the stock given analysts’ price target spread from $275 to $410.
  • Limited disclosure on motive: The filing states the sale was made under a Rule 10b5-1 plan but does not provide further explanation linking the transaction to company developments, leaving the intent behind the sale unspecified.

Risks

  • Recent 10.32% share decline introduces near-term market volatility for the technology and semiconductor sectors.
  • Upcoming February 17 earnings announcement could cause significant stock movement given broad analyst price target range.
  • Regulatory filing confirms the sale was under a Rule 10b5-1 plan but does not explain motivation, leaving uncertainty about insider intentions.

More from Insider Trading

Rush Street Interactive CEO Disposes $4.35 Million in Shares; Analysts Reiterate Views Feb 5, 2026 EverCommerce President Disposes $338,477 in Stock via Prearranged Plan Feb 5, 2026 Kratos EVP and CFO Sells Nearly $484K of KTOS Stock as Company Advances Drone and Hypersonic Programs Feb 5, 2026 aTyr Pharma CEO Sells Small Stake to Cover RSU Taxes as FDA Meeting on Lead Candidate Is Set Feb 5, 2026 Arcutis CEO Sells $505,709 of ARQT Stock to Cover RSU Taxes; Company Posts Robust Growth and Clinical Updates Feb 5, 2026